Patent details

Basic Information

Publication number:

EP3283099

PCT Application Number:

EP2016057662

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167182443

PCT Publication Number:

WO2016166014

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY WITH COAGULATION FACTORS AND MULTISPECIFIC ANTIBODIES

French Title of Invention:

THÉRAPIE DE COMBINAISON AVEC DES ANTICORPS MULTISPÉCIFIQUES ET DES FACTEURS DE COAGULATION

German Title of Invention:

KOMBINATIONSTHERAPIE MIT GERINNUNGSFAKTOREN UND MULTISPEZIFISCHEN ANTIKÖRPERN

SPC Number:

Dates

Filing date:

07/04/2016

Grant date:

02/03/2022

EP Publication Date:

21/02/2018

PCT Publication Date:

20/10/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/03/2022

EP B1 Publication Date:

02/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/04/2022

Expiration date:

07/04/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/02/2022

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

CALATZIS, Andreas

Address:

Germany (DE)

2

Name:

LECHNER, Katharina

Address:

Germany (DE)

Priority

Priority Number:

15164045

Priority Date:

17/04/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 16/36; A61K 38/48; A61K 39/395; A61P 7/04;

Publication

European Patent Bulletin

Issue number:

202209

Publication date:

02/03/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages